About

Siren Interactive is a rare disease marketing agency with unmatched expertise in addressing the challenges and unmet needs of patients, caregivers and physicians dealing with the over 7,000 rare diseases affecting over 300 million people worldwide. For more than 15 years, across more than 30 different disease states, we’ve had 1 focus: finding rare disease patients and connecting them to our clients’ brands. As trailblazers in recognizing that patient-driven decision making is central to successful orphan drug commercialization, we are constantly innovating to meet patients and caregivers where they live. To learn more about our proprietary approaches to building trust relationships with rare disease stakeholders visit sireninteractive.com. Siren Interactive is a subsidiary of Dohmen Life Science Services. More information can be found at DLSS.com.

Siren Interactive is a collection of uncommon thinkers. Each member of our team is driven by a shared focus on orphan drug marketing and reshaping healthcare by being grounded in a single idea: Rare is different. From diagnosis to treatment management, we know that the journey that patients with rare diseases embark on just isn't the same as other people with more common, chronic diseases.